The 3rd European Multidisciplinary Meeting on Urological Cancers (EMUC) raised a vast array of controversial issues in onco-urology and offered essential updates, providing common ground for building bridges across disciplines. More than 900 delegates, exhibitors and faculty joined the event, which proved to be highly interactive and stimulating.
During the meeting, an extended series of state-of-the-art lectures, complemented by seven highly intensive debates, offered an overview of the most current issues in bladder, penile, testicular cancer, as well as PCa and RCC. The format also accommodated for two symposia organised by ASTELLAS and AMGEN, as well as an insightful session on translational research and basic science in urology.
Read all news >
If you have attended the 3rd EMUC, you can download your certificate of attendence from this website. Make sure to have your badge barcode at hand.
The 3rd European Multidisciplinary Meeting on Urological Cancers, Embracing Excellence in Prostate, Bladder and Kidney Cancer, Barcelona, Spain, 4-6 November 2011 is accredited for 15 hours of European CME credits in compliance with the UEMS/EACCME regulations: 1 hour = 1 European CME credit with a maximum of 6 European CME credits per day.
If you would like to review some of the sessions or hear the presentations that you have missed - you can watch EMUC webcasts online. The whole library of webcasts is now at your disposal. A wealth of information, archived and accessible at all times - this collection is a great help for your professional development.
The webcasts can be accessed through the programme.
In this interview, Prof. Norman Maitland discusses the current directions of stem cell research and how these investigations deepen the understanding of urological cancer. Maitland maintains that scientists are now re-thinking much of tumour biology, as the normal rules do not apply in the stem cell compartment.